P2X3, receptor antagonists for treatment of pain
US8598209B2 · kind B2 · utility
8Cited by
8References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 21, 2009 |
| Grant date | Dec 3, 2013 |
| Priority date | — |
| Expiry date | May 27, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The subject invention relates to novel P2X3 receptor antagonists that play a critical role in treating disease states associated with pain, in particular peripheral pain, inflammatory pain, or tissue injury pain that can be treated using a P2X3 receptor subunit modulator.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.